Oliver J. Debski-Antoniak

A broad-spectrum macrocyclic peptide inhibitor of the SARS-CoV-2 spike protein

J. Snijder, B. Bosch, C. Jackson, 2022, bioRxiv.

A broad-spectrum macrocyclic peptide inhibitor of the SARS-CoV-2 spike protein

J. Snijder, B. Bosch, C. Jackson, 2023, bioRxiv.

Neutralizing antibodies reveal cryptic vulnerabilities and interdomain crosstalk in the porcine deltacoronavirus spike protein

B. Bosch, F. V. van Kuppeveld, D. Drabek, 2024, Nature communications.

Exploiting the Affimer platform against influenza A virus

J. Fontana, S. Muench, D. Tomlinson, 2023, bioRxiv.

Unraveling dynamics of paramyxovirus-receptor interactions using nanoparticles displaying hemagglutinin-neuraminidase

C. D. de Haan, Tony Smits, F. Kuppeveld, 2024, PLoS pathogens.